From owner-FreeBSD-users-jp@jp.FreeBSD.org Sun Nov 28 11:53:15 2004
Received: (from daemon@localhost)
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) id iAS2rFT57602;
	Sun, 28 Nov 2004 11:53:15 +0900 (JST)
	(envelope-from owner-FreeBSD-users-jp@jp.FreeBSD.org)
Received: from 202.103.18.20 ([218.244.196.28])
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) with SMTP/inet id iAS2r6857597
	for <freebsd-users-jp@jp.freebsd.org>; Sun, 28 Nov 2004 11:53:08 +0900 (JST)
	(envelope-from hugqinfo@urgentalert.biz)
Message-Id: <200411280253.iAS2r6857597@castle.jp.FreeBSD.org>
Received: from mx2.amisp.net (mx2.amisp.net [216.38.54.226]) by epimetheus.adone.com with smtp; Nov, 27 2004 8:30:51 PM -0200
From: MedCapCorp <hugqinfo@urgentalert.biz>
To: freebsd-users-jp@jp.FreeBSD.org
Mime-Version: 1.0
Content-Type: text/plain; charset="iso-8859-1"
X-Mailer: Microsoft Outlook Express 6.00.2462.0000
Reply-To: FreeBSD-users-jp@jp.FreeBSD.org
Precedence: list
Date: Sat, 27 Nov 2004 21:53:05 -0500
X-Sequence: FreeBSD-users-jp 81968
Subject: [FreeBSD-users-jp 81968] investor update
Sender: owner-FreeBSD-users-jp@jp.FreeBSD.org
X-Originator: hugqinfo@urgentalert.biz
X-Distribute: distribute version 2.1 (Alpha) patchlevel 24e+041128

MedCap Corp Acquires Exclusive Rights to AccuScan Rapid Test Kits
For The Detection of Drugs of Abuse

November 29, 2004

Toronto, Ontario
MedCap Corp (US NASD-OTC:MPCPF) is pleased to announce that it has acquired the exclusive rights 
to market and distribute the AccuScan Drugs of Abuse Rapid Test kits worldwide. The AccuScan test 
kits detect Cocaine, Heroin/Morphine, Marijuana, amphetamines and Methamphetamines. The 
AccuScan test kits can be used individually or in a combination kit that measures all of the above in one 
multiple kit. The Kits give results in under 10 minutes an have an accuracy of greater than 99%.  In the 
current climate of zero tolerance around the world the demand for a rapid test kit that detects Drugs of 
Abuse is huge. The Company anticipates that it will sell in excess of 1,500,000 kits in the first year.

The Company has begun negotiating with several companies to become distributors for the kits. The 
Company hopes to establish a large distribution network by negotiating distribution agreements with 
Companies that already have established distribution networks in different parts of the world. Currently the 
AccuScan test kits are being tested by law enforcement agencies in the People's Republic of China. 
Preliminary test results have been very favorable.

MedCap Corp trades in the United States - NASD-OTC:MPCPF
http://finance.yahoo.com/q?s=MPCPF.pk

For a detailed company bio and product information; 
http://stockwatchers.net-index.ph/click.php?id=onnecai

To unsubscribe from further news alerts;
http://stockwatchers.net-index.ph/click.php?id=onnecax

This release may contain forward-looking statements that involve uncertainties and risks. Actual results 
may differ materially from any results predicted. MedCap undertakes no obligation to release publicly any 
revisions to any forward-looking statements to reflect events of circumstances after the date hereof












bqfqnbbxuvclvncvionjwiqhksqmlqpkxp
